Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Chemours Co Director's Dealing 2021

Oct 1, 2021

31561_dirs_2021-10-01_bb1202a8-22ec-4401-b341-f6c31862d2e7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Chemours Co (CC)
CIK: 0001627223
Period of Report: 2021-09-29

Reporting Person: Wisel Camela (VP, CAO & Controller)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 10198.524 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (Right to Buy) $24.01 2031-03-01 Common Stock (7668) Direct
Stock Option (Right to Buy) $14.43 2030-03-02 Common Stock (13368) Direct
Stock Option (Right to Buy) $38.02 2029-03-01 Common Stock (2264) Direct
Stock Option (Right to Buy) $48.53 2028-03-01 Common Stock (1508) Direct
Stock Option (Right to Buy) $34.72 2027-03-01 Common Stock (1813) Direct

Footnotes

F1: Includes directly owned shares, restricted stock units and dividend equivalent units.

F2: Options vest in three equal installments beginning on March 1, 2022.

F3: Options vest in three equal installments beginning on March 2, 2021.

F4: Options vest in three equal installments beginning on March 1, 2020.

F5: Options are fully vested.